| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 10/28/2004 | WO2003100020A3 Methods and constructs for high yield expression of clostripain |
| 10/28/2004 | WO2003070913A3 Microbial production of pyruvate and other metabolites |
| 10/28/2004 | WO2003070908A3 Novel spinosyn-producing polyketide synthases |
| 10/28/2004 | WO2003030833A3 Angiopoietin-2 specific binding agents |
| 10/28/2004 | WO2002088322A3 Cell adhesion and extracellular matrix proteins |
| 10/28/2004 | WO2001081540A3 Growth factor which acts through erb b-4 rtk |
| 10/28/2004 | US20040216181 Dna construct to confer multiple traits on plants |
| 10/28/2004 | US20040216180 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 10/28/2004 | US20040215008 Production of proteins by autoproteolytic cleavage |
| 10/28/2004 | US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders |
| 10/28/2004 | US20040214990 Transmembrane protein differentially expressed in cancer |
| 10/28/2004 | US20040214787 Cytochrome P-450 gene cluster from rhodococcus ruber and uses thereof in ether fuel cleavage |
| 10/28/2004 | US20040214776 (truncated GDNF) proteins that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells |
| 10/28/2004 | US20040214331 Transforming and propagating viral-like particle in cells; for use as tools in prevention and treatment of viral infection; viricides and genetic vaccines |
| 10/28/2004 | US20040214308 Gamma-glutamylcystein-producing yeast and method of screening the same |
| 10/28/2004 | US20040214307 Novel process for producing L-epi-2-inosose and novel process for producing epi-inositol using microorganisms |
| 10/28/2004 | US20040214306 Rapid growing microorganisms for biotechnology applications |
| 10/28/2004 | US20040214305 Preparing transgenic microorganism with reduced glycolytic flux and which enriches for preferential products under aerobic conditions; preferential gene expression and bioreactors |
| 10/28/2004 | US20040214304 Microbiocidal gastrointestinal microorganism for use in food processing and the prevention of infection; bacteriocin |
| 10/28/2004 | US20040214297 Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives |
| 10/28/2004 | US20040214296 Using transgenic methylophilus to ferment lysine for use in medicines, foods, animal feeds and cosmetics |
| 10/28/2004 | US20040214295 Using Flavobacterium lutescens cells; piperidine-6-carboxylic acid dehydrogenase; genetic engineering |
| 10/28/2004 | US20040214294 Process for the production of L-amino acids using strains of the enterobacteriaceae family |
| 10/28/2004 | US20040214293 Penicillium culture for use in the generation of fructooligosaccharides |
| 10/28/2004 | US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 10/28/2004 | US20040214283 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 10/28/2004 | US20040214282 Prokaryotic collagen-like proteins and uses thereof |
| 10/28/2004 | US20040214281 Methods and compositions for high level expression of a heterologous protein with poor codon usage |
| 10/28/2004 | US20040214279 Insect monoamine transporter and methods of use thereof |
| 10/28/2004 | US20040214276 host cells containing expression systems for production of nucleotide diphosphate 6-deoxy-mycarose; polyketides |
| 10/28/2004 | US20040214275 Von willebrand factor (vmf)-cleaving enzyme |
| 10/28/2004 | US20040214274 via direct fermentation of cyclic depsipeptide; introducing gene involved in biosynthetic pathway from chorismic acid to p-aminophenylpyruvic acid (biosynthesis gene) into a phenylalanine auxotrophic host; antihelmintic; nematocides |
| 10/28/2004 | US20040214271 Process for producing recombined protein |
| 10/28/2004 | US20040214270 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fattly liver in lipid biosynthesis |
| 10/28/2004 | US20040214261 culturing genetically modified microorganism containing polyglutamyl hydrolase (from rodents, mammals, or humans) activity to enhance generation of monoglutamyl folate; food processing; dairy products |
| 10/28/2004 | US20040214235 Immunoglobulin specific to tumor necrosis factor -related apoptosis-inducing ligand (TRAIL) for use in the prevention and treatment of cancer; immnotherapy |
| 10/28/2004 | US20040214225 Immunoglobulin polypeptide for use as diagnostic tool in detecting variable major protein (VMP) of lymes disease; immunodiagnostics and genetic vaccines preventing parasitic infection |
| 10/28/2004 | US20040214219 Nucleotide sequences which code for the tal gene |
| 10/28/2004 | US20040214214 Nucleotide sequences coding obesity polypeptide for use in the diagnosis and treatment of viral, cell proliferative weight control and eating disorders |
| 10/28/2004 | US20040214208 Enterococcal virulence factors |
| 10/28/2004 | US20040214205 Semiconductor comprising DNA constituents for use in genomic analysis; biochips |
| 10/28/2004 | US20040214201 Comprises nucleotide sequence coding polyphenol oxidase for use in identifying modulators which inhibit browning, increase polyphenols and enhance fruit and vegetable flavor |
| 10/28/2004 | US20040214190 Mammalian c-type lectins |
| 10/28/2004 | US20040214185 Regulatory nucleotide sequence fro use as tools in controlling heterologous/endogenous transcription; transcriptional regulators and bioreactors |
| 10/28/2004 | US20040214173 Anti-listeria bacteriocin |
| 10/28/2004 | US20040214172 Sheeplice, bovicola ovis, allergen treatment |
| 10/28/2004 | US20040214171 Cat kidney disease marker |
| 10/28/2004 | US20040214170 Method for effecting site-directed mutagenesis |
| 10/28/2004 | US20040214165 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 10/28/2004 | US20040214160 Using viruses to detect or purify proteins |
| 10/28/2004 | US20040213889 active dry yeasts are placed in an aqueous medium containing in addition one or more nutrients chosen from sources of organic or inorganic nitrogen, vitamins, mineral salts, fatty acids, sterols or natural sources rich in these elements |
| 10/28/2004 | US20040213874 Process for the preparation of d-pantothenic acid and/or salts thereof |
| 10/28/2004 | US20040213810 preparations of bacterial ghosts which are substantially free of living bacterial cells and/or nucleic acids and their use in pharmaceutical preparations |
| 10/28/2004 | US20040213809 Method of treating diseases connected with immunity deficiency |
| 10/28/2004 | US20040213802 Gene of novel corynebacterium diphtheriae antigen |
| 10/28/2004 | US20040213801 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry |
| 10/28/2004 | US20040213797 Conjugates for the modulation of immune responses |
| 10/28/2004 | US20040213793 nucleic acid molecule encoding a transmembrane TEM1; Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a Tumor Endothelial Markers (TEMs) protein; polycystic kidney disease; psoriasis |
| 10/28/2004 | US20040213762 A viral vector containing a nucleic acid sequence encoding V3 polypeptide or a biologically active fragment of the V3 |
| 10/28/2004 | US20040211721 Delivery systems for mycotechnologies, mycofiltration and mycoremediation |
| 10/28/2004 | CA2523693A1 Bacteriophage for lysis of methylobacterium and compositions and uses thereof |
| 10/28/2004 | CA2522985A1 Means and methods for diagnosing and treating affective disorders |
| 10/28/2004 | CA2521754A1 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 10/28/2004 | CA2515340A1 Amylases, nucleic acids encoding them and methods for making and using them |
| 10/28/2004 | CA2511946A1 Purification of polypeptides |
| 10/27/2004 | EP1471150A2 Plasmodium falciparum antigens inducing protective antibodies |
| 10/27/2004 | EP1471149A1 Production of chitosan and chitin |
| 10/27/2004 | EP1471148A2 Production of chitosan and chitin |
| 10/27/2004 | EP1471147A2 Method of making a recombinant molecule for the expression of HPV-16 L1 protein |
| 10/27/2004 | EP1471145A2 Pesticipal proteins and strains |
| 10/27/2004 | EP1471074A2 Methods for improving the conformation of proteins by means of reducing agents |
| 10/27/2004 | EP1471072A1 18 human secreted proteins |
| 10/27/2004 | EP1470420A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 10/27/2004 | EP1470236A2 Methods and compositions for protein expression and purification |
| 10/27/2004 | EP1470227A2 Method for overexpressing dehydrogenases |
| 10/27/2004 | EP1470223A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 10/27/2004 | EP1470158A2 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
| 10/27/2004 | EP1470154A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 10/27/2004 | EP1470145A2 Methods and materials for modulating p2x2 |
| 10/27/2004 | EP1469870A2 Novel compositions and methods for cancer |
| 10/27/2004 | EP1469769A2 Novel compositions and methods for cancer |
| 10/27/2004 | EP1469738A1 Cheese flavour ingredient and method of its production |
| 10/27/2004 | EP1201747B1 Process for producing gamma-glutamylcysteine |
| 10/27/2004 | EP1141022B1 Serine protease inhibitor |
| 10/27/2004 | EP0918854B1 M. tuberculosis complex members mycobacteria specific nucleic acid fragments and their applications for the detection and differential diagnosis of m. tuberculosis complex members |
| 10/27/2004 | CN2651257Y Mechanical agitating reactor |
| 10/27/2004 | CN1541274A Coryneform bacteria which produce chemical compounds II |
| 10/27/2004 | CN1541271A Methods for large scale prodn. of recombinant DNA-derived tPA or K2S molecules |
| 10/27/2004 | CN1541269A Human protooncogene KG-zo and protein encoded therein |
| 10/27/2004 | CN1541266A FCE fusion proteins for treatment of allergy and asthma |
| 10/27/2004 | CN1541265A Identification of DNA variant associated with adult type hypolactasia |
| 10/27/2004 | CN1541264A Lipoxygenase |
| 10/27/2004 | CN1541263A Improved methods for binding AcmA-type protein anchor fusions to cell-wall material of micro-organisms |
| 10/27/2004 | CN1541226A Antibodes specific for CD44V6 |
| 10/27/2004 | CN1541225A Humanized antibodies that recognize beta amyloid peptide |
| 10/27/2004 | CN1541223A Expression of functional human olfactory cyclic nucleotide gated (CNG)channel in recombinant host cells and use thereof in cell based assays to identify smell modulators |
| 10/27/2004 | CN1541111A Mutant forms of cholera holotoxin as adjuvant |
| 10/27/2004 | CN1539989A Method for producing antigen protein in use for hog cholera vaccine |
| 10/27/2004 | CN1539983A Process for fermentative production of L-methionine |
| 10/27/2004 | CN1539978A Expression vector, engineering bacteria of N* deacetylating Alpha 1 monomer of human thymosin, and preparation method |